Abnormal Liver Function in Relation to Hemodynamic Profile in Heart Failure Patients

Journal of Cardiac Failure

Volumn 16, Issue 1, 2010, Pages 84-90

  van Deursen, V M ^a   Damman, K ^a   Hillege, H L ^a   van Beek, A P ^a   van Veldhuisen, D J ^a   Voors, A A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

abnormal liver function; Heart failure; hemodynamics; prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALDOSTERONE ANTAGONIST; ALKALINE PHOSPHATASE; ANGIOTENSIN RECEPTOR ANTAGONIST; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN GLUCURONIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CAUSE OF DEATH; CENTRAL VENOUS PRESSURE; CONCENTRATION (PARAMETERS); FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEART CATHETERIZATION; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMIC PARAMETERS; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; AGED; COMPARATIVE STUDY; HEMODYNAMICS; LIVER DISEASES; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; STANDARDS;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEMODYNAMICS; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 72749128218     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.08.002     Document Type: Article

References (22)

1. Dickstein K., Cohen-Solal A., Filippatos G., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10 (2008) 933-989
2. Jaarsma T., van der Wal M.H., Lesman-Leegte I., et al. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med 168 (2008) 316-324
3. Groenveld H.F., Januzzi J.L., Damman K., et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 52 (2008) 818-827
4. Hillege H.L., Nitsch D., Pfeffer M.A., et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113 (2006) 671-678
5. Macchia A., Monte S., Romero M., D'Ettorre A., and Tognoni G. The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure. Eur J Heart Fail 9 (2007) 942-948
6. Damman K., Navis G., Smilde T.D., et al. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9 (2007) 872-878
7. Damman K., van Deursen V.M., Navis G., Voors A.A., van Veldhuisen D.J., and Hillege H.L. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53 (2009) 582-588
8. Allen L.A., Felker G.M., Pocock S., et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail 11 (2009) 170-177
9. Batin P., Wickens M., McEntegart D., Fullwood L., and Cowley A.J. The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J 16 (1995) 1613-1618
10. Felder L., Mund A., and Parker J.G. Liver function tests in chronic congestive heart failure. Circulation 2 (1950) 286-297
11. Jolliffe N. Liver function in congestive heart failure. J Clin Invest 8 (1930) 419-433
12. Myers J.D., and Hickam J.B. An estimation of the hepatic blood flow and splanchnic oxygen consumption in heart failure. J Clin Invest 27 (1948) 620-627
13. Richman S.M., Delman A.J., and Grob D. Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes. Am J Med 30 (1961) 211-225
14. Sherlock S. The liver in heart failure; relation of anatomical, functional, and circulatory changes. Br Heart J 13 (1951) 273-293
15. Shinagawa H., Inomata T., Koitabashi T., et al. Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. Circ J 72 (2008) 364-369
16. Henrion J., Schapira M., Luwaert R., Colin L., Delannoy A., and Heller F.R. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore) 82 (2003) 392-406
17. Kubo S.H., Walter B.A., John D.H., Clark M., and Cody R.J. Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. Arch Intern Med 147 (1987) 1227-1230
18. Lau G.T., Tan H.C., and Kritharides L. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 90 (2002) 1405-1409
19. Chang C.Y., and Schiano T.D. Review article: drug hepatotoxicity. Aliment Pharmacol Ther 25 (2007) 1135-1151
20. Stevenson L.W., and Perloff J.K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261 (1989) 884-888
21. Naschitz J.E., Slobodin G., Lewis R.J., Zuckerman E., and Yeshurun D. Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 140 (2000) 111-120
22. White T.J., Leevy C.M.L., Brusca A.M., and Gnassi A.M. The liver in congestive heart failure. Am Heart J 49 (1955) 250-257